Jon Congleton - 29 Apr 2026 Form 4 Insider Report for Avalyn Pharma Inc. (AVLN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 May 2026, 18:32:47 UTC
Prior SEC filing
15 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Carlson

Key filing fact

Jon Congleton filed Form 4 for Avalyn Pharma Inc. (AVLN) on 01 May 2026.

Key facts

  • This page summarizes Jon Congleton's Form 4 filing for Avalyn Pharma Inc. (AVLN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 01 May 2026, 18:32.

Change

  • Previous filing in this sequence was filed on 15 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001644975 Primary reporting owner

Congleton Jon

Relationship
Director
Address
C/O AVALYN PHARMA INC., 105 W FIRST STREET, BOSTON
Signature
/s/ Douglas Carlson
Signature date
01 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVLN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+26,978
Change %
Price
$0.000000*
Shares after
26,978
Date
29 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
26,978
Exercise price
$18.00
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .